文献速递自身炎症与 IgG4 相关病

IgG4相关疾病与恶性肿瘤发生率增加无关:一项大型单中心队列研究

IgG4-related disease is not associated with an increased incidence of malignancy in a large, single-centre cohort.
PubMed 文献 · Ann Rheum Dis · 2026-10-08

本研究为单中心回顾性队列研究,纳入348例符合ACR/EULAR分类标准的IgG4相关疾病(IgG4-RD)患者,中位随访8.04年,比较其恶性肿瘤发生率与美国一般人群的差异。吸烟和发病年龄较高与恶性肿瘤风险升高相关,女性和下颌下腺受累与风险降低相关。

要点

  • 女性和下颌下腺受累分别与恶性肿瘤风险降低相关(HR 0.37和0.25)。

核心结论

  • IgG4-RD发病后未观察到恶性肿瘤发生率增加。
  • 吸烟和发病年龄较高与IgG4-RD患者恶性肿瘤风险升高相关。
  • 女性和下颌下腺受累与IgG4-RD患者恶性肿瘤风险降低相关。

研究设计与样本

  • 单中心回顾性队列研究,纳入348例符合ACR/EULAR IgG4-RD分类标准的患者。
  • 通过问卷调查和病历回顾收集恶性肿瘤病史,中位随访8.04年(IQR 1.35-14.72年)。
  • 按年龄和性别分层比较队列与一般美国人群的恶性肿瘤发病率,并采用Cox比例风险模型分析疾病特征与 incident malignancy 的关联。

主要发现

  • 348例患者中34例(10%)在中位随访8.04年期间发生 incident malignancy。
  • 最常见的恶性肿瘤为淋巴瘤(n=6,占16%)、前列腺癌(n=6,16%)和肺癌(n=5,13%)。

关键数值与推荐

  • IgG4-RD诊断采用ACR/EULAR IgG4-RD分类标准。

临床怎么用

  • 对于IgG4-RD患者,无需因疾病本身而普遍增加恶性肿瘤筛查强度,但应结合个体危险因素评估。
  • 吸烟和发病年龄较高的IgG4-RD患者可能需更关注恶性肿瘤筛查。
  • 女性和下颌下腺受累的IgG4-RD患者恶性肿瘤风险可能较低,可据此个体化调整随访策略。

局限性

  • 单中心回顾性队列设计可能限制结果的外推性。
  • 恶性肿瘤病史依赖问卷调查和病历回顾,可能存在信息偏倚。
  • 与一般美国人群比较可能受人群差异影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Immunoglobulin G4-related disease (IgG4-RD) is a systemic, immune-mediated disease-causing inflammation and fibrosis in multiple organs, often associated with elevated serum IgG4 concentrations. Whether IgG4-RD is associated with malignancy remains unclear. We investigated whether there is an association between IgG4-RD and incident malignancy. METHODS: We performed a single-centre, retrospective cohort study of patients who fulfilled the American College of Rheumatology/European Alliance of Associations for Rheumatology IgG4-RD Classification Criteria. Malignancy history was collected by survey and medical record review. Age- and sex-stratified malignancy incidence rates in the cohort were compared with rates in the general US population. Cox proportional hazards were used to identify disease characteristics associated with incident malignancy. RESULTS: Of the 348 patients with IgG4-RD in our cohort, 34 (10%) developed incident malignancies over a median follow-up of 8.04 years (IQR, 1.35-14.72 years). The most common malignancies were lymphoma (n = 6, 16% of malignancies), prostate cancer (n = 6, 16%), and lung cancer (n = 5, 13%). Compared with the general US population, there was no increased incidence of malignancy in patients with IgG4-RD (standardised incidence ratio, 0.88 [0.61-1.23]). Among patients with IgG4-RD, those who ever smoked (adjusted hazard ratio [HR], 2.46 [1.16-5.24]) or were older (HR, 1.35 [1.00-1.83] per decade) had increased risk of malignancy, whereas female patients (HR, 0.37 [0.14-0.96]) and those with submandibular gland involvement (HR, 0.25 [0.10-0.61]) had decreased risk. CONCLUSIONS: IgG4-RD was not associated with an increased incidence of malignancy following IgG4-RD onset. Among patients with IgG4-RD, smoking and older age at IgG4-RD onset were associated with higher malignancy risk. Female sex and submandibular gland involvement were associated with lower malignancy risk.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Michelson DA, McMahon GA, Jha I, et al. IgG4-related disease is not associated with an increased incidence of malignancy in a large, single-centre cohort. Ann Rheum Dis. 2026. PMID: 42850159. doi:10.1016/j.ard.2026.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。